fda warns hims & hers for selling unapproved compounded semaglutide on Certain Forms of Omzo GLP-1 Review 2026: Is
Description
Currently, federal law prohibits Medicare from covering drugs for obesity management, though this policy is under debate
Jeffrey Egler, MD, Chief Medical Officer at Noom
2019;30:329342.e5
Y.ReimannF.GribbleF
Researchers suggest these drugs might be toxic to the kidneys when combined with other medications such as non-steroidal anti-inflammatories for pain relief
Conflict of interest The authors declare that this review was prepared in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest
